Alzheimer's Matters Blog

Wolf Blitzer and Dr. Ron Crystal

Developing Drugs

Gene Therapy, A New Frontier in Alzheimer’s

Dr. Ron Crystal and his team at Weill Cornell developed a gene therapy to replace APOE4 with APOE2, which would significantly lower Alzheimer's risk.

Marlee Berliner and Rachel Williams

Understanding Dementia

Familial Alzheimer’s Disease, Explained

Learn about early-onset familial Alzheimer's disease, which can strike people as early as their 30s or 40s.

Supporter Stories

Loss and Found

Adam Rowe recounts a harrowing experience with his mother, who has frontotemporal dementia. 

Developing Drugs

Alzheimer’s Clinical Trials, Explained

Learn about clinical trials, an important and growing part of our funding at the Alzheimer’s Drug Discovery Foundation. 

ADDF Impact

ADDF Grantees Headline NIH Alzheimer’s Summit

ADDF-supported research was at the forefront of the Summit and the National Plan to Address Alzheimer's.

Understanding Dementia

Types of Dementia (It’s Not Just Alzheimer’s)

While Alzheimer's accounts for more than two-thirds of dementia cases, the ADDF also funds research to prevent and treat the other causes of dementia.